Navigation Links
Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study
Date:3/4/2008

Funds to support research into the effects on the brain following exposure to mercury

NIXA, Mo., March 4 /PRNewswire-USNewswire/ -- It was announced this week that The National Autism Association (NAA) will receive $10,000 for the Burbacher/Charleston study into the effects of mercury exposure in the brain. The Doug Flutie, Jr. Foundation for Autism, Inc. awarded the grant. Funding will support the completion of a research study relating to the effects upon the brain following exposure to mercury.

The mercury study's primary investigator is Dr. Thomas Burbacher, a University of Washington researcher and long-time investigator into the effects of the toxin. His earlier research found that Thimerosal, best known for its use as an ethylmercury-based preservative in infant vaccines and pregnancy shots, is actually more toxic to the brain than methylmercury.

The goal of this particular investigation is to expand the knowledge of a potential link between neurotoxic exposures and the development of autism, which will in turn lead to better treatments.

"As parents of a child with autism, we are concerned about the possible correlation between mercury and autism and are pleased to see NAA continuing to support this very important research that may help resolve the mercury issue," commented Doug and Laurie Flutie.

The second-phase study by Dr. Jay Charleston and Dr. Burbacher will look more in-depth at brain tissue, and the effects mercury may have on this tissue once it passes the blood-brain barrier. In his first-phase study, Burbacher concluded:

-- Ethylmercury is more toxic because it is less stable as a molecule than methylmercury. Like methylmercury, it gains ready access to the brain across the blood-brain barrier.

-- Ethylmercury leaves more than double the amount of inorganic mercury trapped in the brain than does methylmercury.

-- Inorganic mercury trapped in the brain can stay for many years
'/>"/>

SOURCE National Autism Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)... a more convenient regimen than current therapies ... The drug ustekinumab has been shown to be a very ...rate-to-severe psoriasis in two studies published ...umab works by binding to two interleukins, protein...mmatory reactions in diseases like psoriasis. The ...
(Date:5/15/2008)...leadership in proposing prescription,drug marketin...PRNewswire-USNewswire/ -- AARP strongly believes,N...vernor,s prescription,marketing reform proposals w...al companies have over prescribing decisions that ...eatment they receive., The reforms include bannin...
(Date:5/15/2008)...ide cancer incidence, researchers at the Moores Ca... (UCSD) and the Department of Family and Preventiv...deficiency in exposure to sunlight, specifically u...posure triggers photosynthesis of vitamin D3 in th...hrough diet and supplements. , Approximately 1,...
(Date:5/15/2008)...e-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ),... to,discovering, developing and commercializing no...dited financial results for the second fiscal,quar...t loss attributable,to common stockholders of $12....ded March 31, 2008, as compared to a net loss attr...
Breaking Medicine News(10 mins):Health News:Drug Works Well for Moderate-to-Severe Psoriasis 2Health News:AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency 2Health News:UCSD researchers show link between vitamin D status, breast cancer 2Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 2Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 3Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 4Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 5Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 6Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 7Health News:Pharmasset Reports Financial Results for Quarter Ended March 31, 2008 8
...cizumab (Avastin) for first time treatment of adva... // This comes after a large randomised study on l...ancer specialist and director of Thoracic Oncology...Nearly 900 patients with non-small cell lung cance...
...f the world today, Britain had to face the embarra...in Europe' last week. //In a recent report by CABE...h of the nation's population can be declared obese...rchitecture and the Built Environment (CABE) with ...
...d a judicial probe to investigate a botched catara... which 38 people were blinded.// Health Minister ...ucted by a retired judge of the Gauhati High Court... the report in three months. "We are taking the i...
...us type C (GBV-C) protects against HIV infection i...ment of Veterans Affairs (VA) Iowa// City Health C...ied a protein segment that strongly inhibits HIV f...found that an 85-amino acid segment within a GBV-C...
Other Medicine News:Health News:Judicial Probe Ordered for Botched Eye Surgery Camp 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 3
(Date:5/15/2008)... -- Ergonex Pharma today,announced that the United...nted orphan drug designation to Terguride for the .... Terguride is currently being evaluated for PAH,i... grant of orphan drug designation to Terguride for...ogram by offering regulatory,clinical development...
(Date:5/15/2008)...l/ -- Novavax, Inc. (Nasdaq:,NVAX) today announced...Ia,study of its pandemic influenza vaccine includi...e interim results from the first phase of the stud...ult volunteers, were,reported in December 2007. Th...ell tolerated and immunogenic at the 15 microgram ...
(Date:5/15/2008)...ata reports in third quarter ...-FirstCall/ -- VIA Pharmaceuticals,Inc. (Nasdaq: ...velopment of,compounds for the treatment of cardio...leted patient enrollment in its acute coronary syn...hase 2 trials investigating VIA-2291,the company,...
(Date:5/15/2008)...ga 3 fatty acids bound to,phospholipids deserves t...rnative and may have beneficial effect on impulsiv...reveals. While several studies have reported,benef...researchers have,hypothesized that Vectomega(R) co...rol., These research findings have led to the ini...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Fish devastated by sex changing chemicals in municipal wastewater 12090 1Fish devastated by sex changing chemicals in municipal wastewater 12090 2Fish devastated by sex changing chemicals in municipal wastewater 12090 360 Minutes to Report on Dangers of Trasylol 3A Cory Watson Crowder 26 DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG 12087 160 Minutes to Report on Dangers of Trasylol 3A Cory Watson Crowder 26 DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG 12087 2From stem cells to organs 3A The bioengineering challenge 2231 1From stem cells to organs 3A The bioengineering challenge 2231 2USC and second sight announce European clinical trial for Argus II retinal implant 3347 1USC and second sight announce European clinical trial for Argus II retinal implant 3347 2USC and second sight announce European clinical trial for Argus II retinal implant 3347 3
...wswire-FirstCall/ -- On Wednesday,July 11, 2007, ...Central European Time members of Cell Therapeutics...nce call to discuss today,s,announcement of the in...aring CHOP-R to CPOP-R, in which pixantrone is sub...rst-line treatment of patients,with aggressive non...
...ting Editor , ,Celiac disease (CD) is an auto... that is triggered in genetically susceptible pers...ns wheat, rye, barley, and possibly oats. The cond...both a T-cell and B-cell immune response, leading ...t hyperplasia, and is self-perpetuating with conti...
Other Medicine Technology:Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3
Transfuse-ID™, a bedside Transfusion Verification System, is used by hospitals to ensure that a patient receives the specific unit(s) of blood that was typed and crossmatched for them. It has th
...stem helps ensure a safe care environment by autom...he unit dose level. The automated process and reli...ion and handling of all items, including vials, am...reparations and more. This saves valuable time for...
...nsfusion Safety Management system ensures your pat...care. , BloodTrack SafeTx uses the AutoPPI™ b...nt from sample collection to transfusion. SafeTx c...uces the need for bedside paperwork and associated...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product.
Medicine Products: